Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment
Standard
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment. / Leutz, A; Pinter, A; Thaçi, D; Augustin, M; Schuster, C; Fotiou, K; Hundemer, H P; Saure, D; Mrowietz, U; Reich, K.
In: BRIT J DERMATOL, Vol. 184, No. 3, 03.2021, p. 548-550.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment
AU - Leutz, A
AU - Pinter, A
AU - Thaçi, D
AU - Augustin, M
AU - Schuster, C
AU - Fotiou, K
AU - Hundemer, H P
AU - Saure, D
AU - Mrowietz, U
AU - Reich, K
PY - 2021/3
Y1 - 2021/3
U2 - 10.1111/bjd.19558
DO - 10.1111/bjd.19558
M3 - Other (editorial matter etc.)
C2 - 32940343
VL - 184
SP - 548
EP - 550
JO - BRIT J DERMATOL
JF - BRIT J DERMATOL
SN - 0007-0963
IS - 3
ER -